Entrada Therapeutics, Inc. · NASDAQ:TRDA
MPM BioVentures 2018 GP LLC sold 259,837 Entrada Therapeutics, Inc. shares (Form 4)
Traded Sep 4 to Sep 9, 2026 · Filed Sep 9, 2026
From Sep 4 to Sep 9, 2026, MPM BioVentures 2018 GP LLC (10% owner) sold 259,837 Entrada Therapeutics, Inc. shares at an average US$7.33 for US$1.91M, leaving 3,885,115 shares. Filed Sep 9, 2026 (Form 4).
- Sold
- 259,837 shares
- Price
- US$7.33 average (US$7.11 to US$7.41)
- Value
- US$1.91M
- Holding after
- 3,885,115 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 38,500 | US$7.11 | 4,106,452 | Indirect |
| Sep 8, 2026 | Common Stock | Sale | 192,500 | US$7.41 | 3,913,952 | Indirect |
| Sep 9, 2026 | Common Stock | Sale | 28,837 | US$7.13 | 3,885,115 | Indirect |
Source
Related
- Entrada Therapeutics, Inc.
- MPM BioVentures 2018 GP LLC
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026
- Form 4 · Dowden Nathan J · Sep 3, 2026